Washington, DC Hemp & Hemp‑Derived Cannabinoid Laws

This guide provides educational, state‑specific information on hemp and hemp‑derived cannabinoid laws in Washington, DC. It is for educational purposes only and not legal advice.

Washington D.C., DC, USA hemp laws: quick overview

Washington, DC defines “hemp” in alignment with the 2018 Farm Bill as Cannabis sativa L. and any part thereof with a delta‑9‑THC concentration of not more than 0.3% on a dry weight basis, per D.C. Official Code § 48‑901.02(3) ([abca.dc.gov](https://abca.dc.gov/sites/default/files/dc/sites/abra/publication/attachments/Legal%20Analysis%20-%20Whether%20CBD%20Is%20Cannabis%20%28AL-21-222%29_0.pdf?utm_source=openai)). The District does not appear to establish a separate “total THC” threshold or per‑serving limit beyond that federal baseline; no statute was found within the last 24 months specifying a total‑THC percent or mg per serving/container limit, so those remain null. DC law treats any controlled‑substance analogue intended for human consumption as a Schedule I controlled substance under § 48‑902.14 ([code.dccouncil.gov](https://code.dccouncil.gov/us/dc/council/code/sections/48-902.14?utm_source=openai)). Additionally, synthetic cannabinoids are broadly prohibited under the DC Controlled Substances Act (Title 48, Chapter 9) as Schedule I substances ([code.dccouncil.gov](https://code.dccouncil.gov/us/dc/council/code/titles/48/chapters/9/index.full.html?utm_source=openai)). The Medical Cannabis Clarification and Program Enforcement Amendment Act of 2024 (D.C. Law 25‑255, effective December 17, 2024) creates a presumption that any product labeled as containing cannabis or THC is cannabis unless proven otherwise, reinforcing that hemp products must not be marketed as cannabis without proper licensing ([code.dccouncil.gov](https://code.dccouncil.gov/us/dc/council/laws/25-255?utm_source=openai)).

Shipping guidance

DC does not have a specific hemp shipping framework; hemp products may be shipped into DC under federal law, but any product that exceeds Δ9‑THC 0.3% is cannabis and subject to cannabis regulation. No age‑verification or retailer registration rules specific to hemp shipments were located.

Testing & COA guidance

No DC‑specific lab testing rules for hemp were found in the last 24 months. DC does not appear to require ISO 17025 accreditation, specific testing panels, or COA retention for hemp products. Testing requirements default to federal standards or are undefined.

What to buy

Hemp products in DC that contain Δ9‑THC ≤ 0.3% dry weight and are not marketed as cannabis may be purchased by adults. This includes CBD oils, tinctures, topicals, and other non‑intoxicating hemp‑derived products compliant with the Δ9‑THC limit.

What to avoid

Avoid products marketed as cannabis or containing controlled‑substance analogues or synthetic cannabinoids, which are treated as Schedule I. Products labeled as containing THC or cannabis may be presumed cannabis under D.C. Law 25‑255. Delta‑8, Delta‑10, HHC, THCa, or other novel cannabinoids are not specifically addressed and may be considered analogues or synthetic—status unknown or potentially prohibited.

How to shop compliant, tested hemp

• DC defines hemp consistent with federal: Δ9‑THC ≤ 0.3% dry weight (D.C. Official Code § 48‑901.02(3))
• Any controlled‑substance analogue intended for human consumption is treated as Schedule I (D.C. Code § 48‑902.14)
• Synthetic cannabinoids are prohibited under DC Controlled Substances Act (Title 48, Chapter 9)
• Medical/recreational cannabis rules apply separately; hemp products must not be labeled or sold as cannabis without license (D.C. Law 25‑255, effective 2024‑12‑17)

Helpful resource: Learn more about Washington D.C., DC, USA

Educational content only — not legal or medical advice.

FAQ